Made possible by charitable contributions from Astellas / Pfizer , Bayer  and Cyberknife/Accuray . T hank You!


March is on its way, spring is just around the corner and we’re pleased to provide you with the March 2018 issue of the Hot SHEET newsletter .

We recognize that many men who are diagnosed with prostate cancer, or are managing the disease, experience some level of anxiety and/or depression. But it’s not always effectively treated, in part because the symptoms may not be recognized. In response, we’ve developed a new web page with information for survivors and caregivers on recognizing and managing anxiety, depression and prostate cancer : .

Read more about anxiety, depression and stress in the February 2018 issue of Prostatepedia magazine ( ), which features a related article from Us TOO ( ).

We encourage you to check out the various programs and content from Us TOO that provide educational resources, support services and personal connections to the prostate cancer community at no charge:

  • Us TOO website (
  • Support group meetings/services & telephone support group
  • Support group leader resources
  • Inspire online prostate cancer communities (
  • Toll-free Us TOO Prostate Cancer HelpLine (1-800-808-7866); including matching callers with similar survivors for peer-to-peer conversations
  • Personalized connections for one-to-one support
  • Monthly Hot SHEET newsletter
  • Frequent 'News You Can Use' updates and articles
  • Educational videos on informed decision making
  • Military veterans resources – Agent Orange information
  • Genetics and genomic testing
  • Educational events and presentations
  • Educational content – digital and printed

The Metastatic Prostate Cancer Project takes a new approach to cancer research in which researchers partner directly with men with metastatic and/or advanced prostate cancer, who share their samples and clinical information in order to speed up important discoveries. The project is being launched and funded by the Broad Institute of MIT and Harvard — a non-profit academic research institution with a mission to dramatically accelerate the understanding and treatment of disease — and conducted in collaboration with Dana-Farber Cancer Institute and our advocacy partners. The project invites participation from men around the country with metastatic and/or advanced prostate cancer to study their cancer using cutting-edge genomic and molecular research studies performed at the Broad Institute. Learn more at: .

Take care, enjoy the extra sunshine and let us know how we can help you with educational resources, support services and personal connections to others in the prostate cancer community.

All the best,

Chuck Strand, Chief Executive Officer
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Manager
Amy Woods, Director of Development